Trial NCT00051701

View at ClinicalTrials.gov 
Org. Study IDs: CAM.NHL232
Secondary IDs: BLA 99-0786

Last trial update was posted on 2015-03-05

MeSH Interventions

Alemtuzumab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin

Other Conditions

Non-Hodgkins Lymphoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID